化妆品
Search documents
国家药监局:2025年发现50批次化妆品不符合规定
Yang Shi Xin Wen· 2026-02-05 03:03
(文章来源:央视新闻) 国家药监局目前根据《化妆品监督管理条例》《化妆品生产经营监督管理办法》《化妆品抽样检验管理 办法》,要求浙江、广东、青海省药品监督管理部门对上述不符合规定化妆品涉及的注册人、备案人、 受托生产企业等依法立案调查,责令相关企业依法采取风险控制措施并开展自查整改。各省级药品监督 管理部门要依法责令相关化妆品经营者停止经营上述化妆品,并依法调查其进货查验记录等情况,对违 法产品进行追根溯源,发现违法行为的,依法严肃查处;涉嫌犯罪的,依法移送公安机关。 记者今天(5日)从国家药监局获悉,2025年国家化妆品抽样检验发现,50批次化妆品不符合规定,包 括标称为俏因子草本清肌泥膜粉,菌落总数、霉菌和酵母菌总数超出规定要求;标称为香雪兰强力去屑 蓬松柔软洗发乳,检测发现丙烯酰胺含量超出规定要求;标称为优佳隔离多效亮肤防晒乳SPF50+ PA++++(瑞士进口),在成分对比项目中,发现检出产品标签及注册资料载明的技术要求未标示的防 晒剂对甲氧基肉桂酸异戊酯;未检出产品标签及注册资料载明的技术要求标示的防晒剂:水杨酸乙基己 酯、乙基己基三嗪酮、亚甲基双-苯并三唑基四甲基丁基酚、双-乙基己氧苯酚甲氧苯基三 ...
港股巨子生物盘中涨超8%
Mei Ri Jing Ji Xin Wen· 2026-02-05 02:59
Group 1 - The stock of Giant Bio (02367.HK) increased by over 8% during the trading session, with a current rise of 7.03% to HKD 34.4 [1] - The trading volume reached HKD 256 million [1]
新消费概念股再获市场追捧 巨子生物涨超5%
Xin Lang Cai Jing· 2026-02-05 02:29
Group 1 - The new consumption concept in Hong Kong stocks is showing active performance, with notable increases in companies such as Giant Bio (+5.54%), Mao Geping (+4.42%), Miniso (+3.92%), and Pop Mart (+3.79%) [2][3] - The State Council has issued a plan to accelerate the cultivation of new growth points in service consumption, focusing on enhancing key areas such as transportation, housekeeping, online audio-visual services, and inbound consumption [2][4] Group 2 - Pop Mart's new product series, PUCKY and Starry People, have gained significant popularity, with market estimates suggesting that the valuation of Pop Mart's IP potential is still underestimated [5] - Recent trends indicate that Pop Mart's new products are selling out on official websites and commanding high premiums on second-hand platforms, with hidden versions priced at 2-3 times and 3-6 times their original prices [5] - The cosmetics industry is projected to grow, with a retail sales increase of 6.18% year-on-year in 2023, as consumer spending stabilizes and the demand for product upgrades continues [5] Group 3 - The channel landscape is showing differentiated characteristics, with platforms like Douyin leading in sales and Tmall achieving its best growth in four years during the Double Eleven shopping festival [6] - Local brands are steadily increasing their market share, although market differentiation is intensifying, with companies like Anta, Pop Mart, and Haidilao identified as industry favorites for optional consumption [6][7] - Five major investment themes have been identified for 2026, focusing on emotional value consumption, health and wellness needs, the silver economy, emerging channel penetration, and multi-brand strategies [7]
化妆品公司e.l.f. Beauty Q3盈利远超预期,上调全年业绩指引
Ge Long Hui A P P· 2026-02-05 02:09
格隆汇2月5日|美国化妆品公司e.l.f. Beauty公布2026财年第三季度业绩,净销售额同比增长38%至4.9亿 美元,高于市场预期的4.6亿美元,主要得益于零售商和电子商务渠道的增长;经调整每股盈利1.24美 元,远超市场预期的0.72美元。展望2026财年,公司提高业绩指引,预计营收将介于16亿至16.1亿美元 之间,调整后每股收益将介于3.05至3.10美元之间,对比市场预期分别为15.7亿和2.87美元。 ...
【省药监局】陕西强化“两品一械”监管
Shan Xi Ri Bao· 2026-02-05 00:30
Core Insights - In 2025, Shaanxi aims to enhance law enforcement collaboration across provincial and municipal levels, targeting 2,678 cases related to "two products and one device" (drugs, cosmetics, and medical devices) and transferring 56 cases to judicial authorities [1] Group 1: Regulatory Focus - Shaanxi's regulatory efforts have concentrated on high-risk enterprises, high-risk products, and critical production processes, ensuring compliance with drug quality management standards [1] - The province has implemented a "rectification follow-up" mechanism to track the compliance of enterprises with corrective actions [1] Group 2: Online Sales Regulation - To address challenges posed by online drug sales, Shaanxi has strengthened integrated supervision of online and offline sales, emphasizing corporate responsibility [1] - The province is focusing on cracking down on illegal online drug sales, including unqualified sales and prescription drugs sold without prescriptions [1] Group 3: Regulatory Efficiency - Shaanxi is promoting service-oriented law enforcement in drug regulation, allowing for leniency in minor violations through a "first violation not penalized" list [1] - The province is also piloting reforms to optimize the review and approval process for supplementary drug applications [1] Group 4: Future Initiatives - Shaanxi plans to enhance high-level regulation throughout the drug lifecycle, continuing initiatives such as the "clean source" action in drug operations and a three-year improvement plan for cosmetic production quality management systems [2]
林清轩创始人孙来春:想做世界前五的化妆品集团真的是吹牛吗?
Mei Ri Jing Ji Xin Wen· 2026-02-04 18:10
Core Viewpoint - Lin Qingxuan, a high-end domestic skincare brand, aims to become one of the world's top five cosmetics groups by 2025, reflecting a significant shift in the Chinese beauty market towards domestic brands [2][4][8]. Company Overview - Lin Qingxuan is set to go public on the Hong Kong Stock Exchange on December 31, 2025, marking a significant milestone for the company and its founder, Sun Laichun [2]. - The company has experienced a transformation from a struggling domestic brand to a competitive player in the high-end skincare market, with a focus on quality and consumer engagement [5][11]. Market Dynamics - The Chinese beauty market is projected to exceed 1.1 trillion yuan by 2025, with domestic brands capturing 57.37% of the market share, a notable increase from less than 30% two decades ago [8][9]. - The rise of domestic brands is attributed to improved supply chains, research capabilities, and the emergence of new sales channels, particularly e-commerce and live streaming [7][8]. Strategic Goals - Sun Laichun emphasizes the importance of having ambitious goals, stating that Lin Qingxuan's vision is not just to be another domestic brand but to establish itself as a world-class cosmetics group [4][8]. - The company plans to expand its store presence, invest in research and smart manufacturing, and develop a product matrix focused on key categories such as creams, masks, sunscreens, and toners [12]. Consumer Trends - The current consumer base is characterized by a preference for quality over brand loyalty, with a growing number of consumers willing to choose domestic products that meet their standards [9]. - The market is described as a "blue ocean" for mid-range consumers who value product experience, providing an opportunity for domestic high-end brands to thrive [9]. Organizational Development - Post-IPO, Lin Qingxuan will focus on organizational development and brand aesthetics, recognizing that these elements are crucial for achieving global recognition [11]. - The company has initiated collaborations with cultural institutions to enhance its brand narrative and aesthetic appeal [11]. Future Outlook - Lin Qingxuan is actively seeking to expand internationally, with plans to open stores in Southeast Asia, emphasizing brand presence rather than just supply chain expansion [12]. - The founder's philosophy centers on continuous improvement and resilience, viewing challenges as opportunities for growth [12][14].
趾俾坟凯文·沃什被特朗普提名为美联储主席!其妻子是雅诗兰黛继承人,岳父是特朗普60年老友,曾建议他买下格陵兰岛!专家:今年一定会降息-美债-鲍威尔-小
Sou Hu Cai Jing· 2026-02-04 14:05
Group 1 - The core point of the article is the nomination of Kevin Walsh as the next Federal Reserve Chairman by President Trump, which requires Senate approval [1] - Walsh, who served as a Federal Reserve Governor from 2006 to 2011, is known for his hawkish monetary policy stance but has recently aligned with Trump's views on interest rate cuts and tariffs [1][6] - Trump's criticism of current Fed Chairman Powell and his desire for lower interest rates are central to the nomination process, with Trump expressing that rates should be among the lowest globally [1][7] Group 2 - Walsh has a diverse background, having worked in government, finance, and academia, and is currently a partner at Duquesne Family Office and a visiting scholar at Stanford [5] - His previous experience includes serving as a special assistant to President George W. Bush and as an executive director at Morgan Stanley [5][6] - Walsh's relationship with Trump and his commitment to supporting interest rate cuts are seen as significant factors in his nomination [11][13] Group 3 - The Senate's approval process for the Federal Reserve Chairman is crucial, especially in the current politically divided environment, where bipartisan support is necessary [11] - Experts believe that while Walsh's views align with Trump's, the independence of the Federal Reserve is paramount, and decisions are made collectively by the Federal Open Market Committee [13] - There is a consensus among analysts that the Federal Reserve is likely to cut rates this year, with expectations ranging from 50 to 100 basis points [11][13]
敷尔佳:公司2025年备案化妆品产品48个
Xin Lang Cai Jing· 2026-02-04 13:57
Group 1 - The company, Fuhua, plans to register 48 cosmetic products by 2025, covering various forms such as water, lotion, cream, and essence [2][5] - Detailed product registration information can be found on the National Medical Products Administration website [2][5]
贝泰妮:目前薇诺娜等品牌在中东等新兴市场的业务正处于市场引入与本土化运营的早期阶段
Zheng Quan Ri Bao Wang· 2026-02-04 13:40
Core Viewpoint - Betaini (300957) is in the early stages of market introduction and localization operations for its brands, such as Winona, in emerging markets like the Middle East, and the company expresses confidence in the long-term development of overseas markets [1] Group 1 - The company is steadily advancing foundational work, including market education and channel development, to provide professional skincare solutions for sensitive skin to local consumers [1] - Specific market performance and financial data will be disclosed in the company's upcoming periodic reports [1]
敷尔佳:公司2025年完成了两款新原料备案
Zheng Quan Ri Bao Zhi Sheng· 2026-02-04 13:35
Core Viewpoint - The company, Fuhua, announced that it has completed the registration of two new raw materials, "Feruloyl Tripeptide-129 Amide" and "Acetyl Tyrosyl Cyclo D-Glutamyl Tripeptide-110 Amide," which are expected to enhance its product matrix by enabling further product development [1] Group 1 - The company plans to develop products based on the newly registered raw materials [1] - The registration of the new raw materials is expected to be completed by 2025 [1] - Detailed information regarding the raw material registration can be found on the National Medical Products Administration website [1]